The Integrated Bioinformatic Assay of Genetic Expression Features and Analyses of Traditional Chinese Medicine Specific Constitution Reveal Metabolic Characteristics and Targets in Steatosis of Nonalcoholic Fatty Liver Disease

References

• Federation I.D. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.
   Google Scholar
• Liu N, Wang G, Liu C, et al. Non-Alcoholic Fatty Liver Disease and Complications in Type 1 and Type 2 Diabetes: A Mendelian Randomization Study. Diabetes Obes Metab; 2022.
   Google Scholar
• Riazi K, Azhari H, Charette JH, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2022;7(9):851–861. doi:10.1016/S2468-1253(22)00165-0
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou F, Wang W, et al. Epidemiological features of NAFLD from 1999 to 2018 in China. Hepatology. 2020;71(5):1851–1864. doi:10.1002/hep.31150
   PubMed Web of Science ®Google Scholar
• Devarbhavi H, Asrani SK, Arab JP, et al. Global burden of liver disease: 2023 update. J Hepatol. 2023;79(2):516–537. doi:10.1016/j.jhep.2023.03.017
   PubMed Web of Science ®Google Scholar
• Song SJ. Reconstruction of Chinese medicine diagnosis and treatment system under the background of modern medicine. J Tradit Chin Med. 2018;59(1):6–9.
   Google Scholar
• Wang Q. Primary compiling of constitution in Chinese medicine questionnaire. Chin J Clin Rehabilit. 2006;10(3):12–14.
   Google Scholar
• Lu ZY, et al. Preliminary assessment on performance of constitution in Chinese medicine questionnaire. Chin J Clin Rehabilit. 2006;10(3):15–17.
   Google Scholar
• Zhu YB, Wang Q, Origasa H. Evaluation on reliability and validity of the Constitution in Chinese Medicine Questionnaire (CCMQ). Zhongguo Xing Wei Yi Xue Ke Xue. 2007;16:651–654.
   Google Scholar
• Qi W, Dong J, Wu H, Wang DP, Yao SL, Ren XJ. Study on the Molecular Characteristic in Phlegm-Dampness Constitution. Engineering Sciences; 2008.
   Google Scholar
• Li L, Feng J, Yao H, et al. Gene expression signatures for phlegm-dampness constitution of Chinese medicine. Life Sci. 2017;60(1):105–107. doi:10.1007/s11427-016-0212-9
   Web of Science ®Google Scholar
• Wang Q. 阳虚体质者内分泌及免疫功能变化 [Changes of endocrine and immune function in subjects of yang deficiency constitution]. Zhong xi yi jie he xue bao. 2008;6(12):1226–1232. Chinese. doi:10.3736/jcim20081204
   PubMedGoogle Scholar
• Wang Q, Yao S. Molecular basis for cold-intolerant yang-deficient constitution of traditional Chinese medicine. Am J Chin Med. 2008;36(5):827–834. doi:10.1142/S0192415X08006272
   PubMed Web of Science ®Google Scholar
• Zhao Y. Study on TCM syndromes of 3398 patients with metabolic syndrome. Liaoning J Tradit Chin Med. 2016;2016:1.
   Google Scholar
• Zhou LB. Basic biology research on different types of syndrome of obese type 2 diabetes. China J Trad Chin Med Pharm. 2009;24(8):1023–1027.
   Google Scholar
• Meng L, Wu T, Ji G, Zheng P-Y. Applications of metabolomics technology in traditional Chinese medicine treatment of non-alcoholic fatty liver disease. World Chin J Digestol. 2015;23(7):1045. doi:10.11569/wcjd.v23.i7.1045
   Google Scholar
• Cai X, Wang M, Liu S, et al. Establishment and validation of a nomogram that predicts the risk of type 2 diabetes in obese patients with non-alcoholic fatty liver disease: a longitudinal observational study. Am J Transl Res. 2022;14(7):4505–4514.
   PubMed Web of Science ®Google Scholar
• Yang M. Professor Wei Zixiao’s treatment thoughts for pre-diabetes by TCM syndrome differentiation with the idea of preventive treatment of disease. World Chin Med. 2017;012(004):846–849.
   Google Scholar
• Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013;41:D991–D995. doi:10.1093/nar/gks1193
   PubMed Web of Science ®Google Scholar
• Arendt BM, Comelli EM, Ma DWL, et al. Altered hepatic gene expression in nonalcoholic fatty liver disease is associated with lower hepatic n-3 and n-6 polyunsaturated fatty acids. Hepatology. 2015;61(5):1565–1578. doi:10.1002/hep.27695
   PubMed Web of Science ®Google Scholar
• Guo J, Fang W, Sun L, et al. Ultraconserved element uc.372 drives hepatic lipid accumulation by suppressing miR-195/miR4668 maturation. Nat Commun. 2018;9(1):612. doi:10.1038/s41467-018-03072-8
   PubMedGoogle Scholar
• López-Riera M, Conde I, Quintas G, et al. Non-invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers. Sci Rep. 2018;8(1):10606. doi:10.1038/s41598-018-28854-4
   PubMed Web of Science ®Google Scholar
• Torre D, Lachmann A, Ma’ayan A. BioJupies: automated generation of interactive notebooks for RNA-seq data analysis in the cloud. Cell Syst. 2018;7(5):556–561.e3. doi:10.1016/j.cels.2018.10.007
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Tan Q, et al. DAVID Bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007;35(Web Server issue):W169–W175. doi:10.1093/nar/gkm415
   PubMed Web of Science ®Google Scholar
• Liao Y, Wang J, Jaehnig EJ, et al. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019;47(W1):W199–W205. doi:10.1093/nar/gkz401
   PubMed Web of Science ®Google Scholar
• Ge SX, Son EW, Yao R. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data. BMC Bioinform. 2018;19(1):534. doi:10.1186/s12859-018-2486-6
   PubMed Web of Science ®Google Scholar
• Mootha VK, Lindgren CM, Eriksson K-F, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34(3):267–273. doi:10.1038/ng1180
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545–15550. doi:10.1073/pnas.0506580102
   PubMed Web of Science ®Google Scholar
• National Workshop on Fatty Liver and Alcoholic Liver Disease, et al. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: a 2018 update. J Prac Hepatol. 2018;21(02):30–39.
   Google Scholar
• Wen S, Wang C, Gong M, et al. An overview of energy and metabolic regulation. Sci China Life Sci. 2019;62(6):771–790. doi:10.1007/s11427-018-9371-4
   PubMed Web of Science ®Google Scholar
• Gong M, et al. Converging relationships of obesity and hyperuricemia with special reference to metabolic disorders and plausible therapeutic implications. Target Ther. 2020;13:943–962.
   Google Scholar
• Dai X, Feng J, Chen Y, et al. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Chin Med. 2021;16(1):68. doi:10.1186/s13020-021-00469-4
   PubMed Web of Science ®Google Scholar
• Qi W. Classification and diagnosis basis of nine basic constitutions in Chinese medicine. J Beijing Univ Trad Chin Med. 2005;2005:1.
   Google Scholar
• Xiaoqiu WU. Investigation of traditional Chinese medical constitution of type 2 diabetes mellitus patients and its relationship with insulin resistance and insulin secretion. J Guangzhou Univ Trad Chin Med. 2013.
   Google Scholar
• Q. LZ, et al. Analysis about the relationship between the procedure of type 2 diabetes and the liver in traditional Chinese medicine. Int J Trad Chin Med. 2011;33(6):524–526.
   Google Scholar
• Chu JK, Huo XH, Jin-Cheng MA. TCM symptoms distribution characteristics of nonalcoholic fatty liver disease and its related logistic factors analysis. China J Trad Chin Med Pharm. 2021;2021:1.
   Google Scholar
• Bonnet F, Ducluzeau P-H, Gastaldelli A, et al. Liver enzymes are associated with hepatic insulin resistance, insulin secretion, and glucagon concentration in healthy men and women. Diabetes. 2011;60(6):1660–1667. doi:10.2337/db10-1806
   PubMed Web of Science ®Google Scholar
• Ahn HR, Shin MH, Nam HS, et al. The Association Between Liver Enzymes and Risk of Type 2 Diabetes: The Namwon Study. Diabetology & Metabolic Syndrome; 2014.
   Google Scholar
• Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters. Drug Metab Rev. 2017;49(2):197–211. doi:10.1080/03602532.2017.1293683
   PubMed Web of Science ®Google Scholar
• Wang J, Wang Q, Li L, et al. Phlegm-dampness constitution: genomics, susceptibility, adjustment and treatment with traditional Chinese medicine. Am J Chin Med. 2013;41(2):253–262. doi:10.1142/S0192415X13500183
   PubMed Web of Science ®Google Scholar
• Sternisha SM, Miller BG. Molecular and cellular regulation of human glucokinase. Arch Biochem Biophys. 2019;663:199–213. doi:10.1016/j.abb.2019.01.011
   PubMed Web of Science ®Google Scholar
• Chambers KF, Day PE, Aboufarrag HT, et al. Polyphenol effects on cholesterol metabolism via bile acid biosynthesis, CYP7A1: a review. Nutrients. 2019;11(11):2588. doi:10.3390/nu11112588
   PubMed Web of Science ®Google Scholar
• Wahlström A, Sayin S, Marschall H-U, et al. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 2016;24(1):41–50. doi:10.1016/j.cmet.2016.05.005
   PubMed Web of Science ®Google Scholar
• McCreight LJ, Bailey CJ, Pearson ER. Metformin and the gastrointestinal tract. Diabetologia. 2016;59(3):426–435. doi:10.1007/s00125-015-3844-9
   PubMed Web of Science ®Google Scholar
• Pathak P, Xie C, Nichols RG, et al. Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism. Hepatology. 2018;68(4):1574–1588. doi:10.1002/hep.29857
   PubMed Web of Science ®Google Scholar
• Talmud PJ, Drenos F, Shah S, et al. Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet. 2009;85(5):628–642. doi:10.1016/j.ajhg.2009.10.014
   PubMed Web of Science ®Google Scholar
• Hendriks IA, Lyon D, Young C, et al. Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation. Nat Struct Mol Biol. 2017;24(3):325–336. doi:10.1038/nsmb.3366
   PubMed Web of Science ®Google Scholar
• Zhou Y, Ren H, Dai B, et al. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts. J Exper Clin Cancer Res. 2018;37(1):324. doi:10.1186/s13046-018-0965-2
   PubMed Web of Science ®Google Scholar
• La Sala L, Mrakic-Sposta S, Tagliabue E, et al. Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D. Cardiovasc Diabetol. 2019;18(1):18. doi:10.1186/s12933-019-0824-2
   PubMedGoogle Scholar
• Chen Y, Takikawa M, Tsutsumi S, et al. PHLDA 1, another PHLDA family protein that inhibits Akt. Cancer Sci. 2018;109(11):3532–3542. doi:10.1111/cas.13796
   PubMed Web of Science ®Google Scholar
• Liu T, Zhou Y, Ko KS, et al. Interactions between Myc and mediators of inflammation in chronic liver diseases. Mediators Inflamm. 2015;2015:276850. doi:10.1155/2015/276850
   PubMed Web of Science ®Google Scholar
• Zuo C, Li X, Huang J, et al. Osteoglycin attenuates cardiac fibrosis by suppressing cardiac myofibroblast proliferation and migration through antagonizing lysophosphatidic acid 3/matrix metalloproteinase 2/epidermal growth factor receptor signalling. Cardiovasc Res. 2018;114(5):703–712. doi:10.1093/cvr/cvy035
   PubMed Web of Science ®Google Scholar
• Petretto E, Sarwar R, Grieve I, et al. Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet. 2008;40(5):546–552. doi:10.1038/ng.134
   PubMed Web of Science ®Google Scholar
• Mori S. Association of genetic variations of genes encoding thrombospondin, type 1, domain-containing 4 and 7A with low bone mineral density in Japanese women with osteoporosis. J Hum Genet. 2008;53(8):694–697. doi:10.1007/s10038-008-0300-4
   PubMed Web of Science ®Google Scholar
• Hernández-Oliveras A. Histone deacetylase inhibitors promote ATP2A3 gene expression in hepatocellular carcinoma cells: p300 as a transcriptional regulator. Int J Biochem Cell Biol. 2019;113:8–16. doi:10.1016/j.biocel.2019.05.014
   PubMed Web of Science ®Google Scholar
• Decmann A, et al. MicroRNA expression profiling in adrenal myelolipoma. J Clin Endocrinol Metab. 2018;103(9):3522–3530. doi:10.1210/jc.2018-00817
   PubMed Web of Science ®Google Scholar